Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials

ObjectivesTo assess the clinical efficacy and toxicity of nimotuzumab in combination with chemoradiotherapy or chemoradiotherapy alone in the treatment of cervical cancer.MethodsThe PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, China Biomedical Medicine,...

Full description

Bibliographic Details
Main Authors: Yan Yuan, Jiuzhou Chen, Miao Fang, Yaru Guo, Xueqing Sun, Dehong Yu, Yilong Guo, Yong Xin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
cervical cancer
nimotuzumab
chemoradiotherapy
chemotherapy
radiotherapy
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.994726/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.994726/full

Similar Items